Partnering Opportunities

Leiden University and Leiden University Medical Center (LUMC) are seeking commercial partners for collaborative development or licensing of the below mentioned technologies.

Method for generating PRRS vaccination strains

arterivirus, PRRSV, swine, pig, vaccine, frameshift, antivirals Go to technology

RNA-targeted therapy for von Willebrand Disease

small interfering RNA, inherited bleeding disorder, von Willebrand’s factor, thrombocytopenia, bleeding, RNA-targeted therapy, immunology Go to technology

Mouse models of spontaneous thrombosis

Go to technology

Filter categories